Reginster J Y, Albert A, Franchimont P
Calcif Tissue Int. 1985 Dec;37(6):577-80. doi: 10.1007/BF02554908.
The effectiveness of Synthetic Salmon Calcitonin (SSCT) administered as a nasal spray was assessed via clinical, biological, and radiological variables in 5 Pagetic patients during a 6 months course therapy, the results show that intranasal administration does not decrease the activity of SSCT in Paget's disease of bone.
通过临床、生物学和放射学变量,对5名佩吉特病患者在6个月疗程中使用鼻喷雾剂形式的合成鲑鱼降钙素(SSCT)的有效性进行了评估,结果显示经鼻给药不会降低SSCT在骨佩吉特病中的活性。